Nova Patents
AT496144T

Tagged oliggonucleotides and their use in nucleic acid amplification methods

Abstract

This record has no abstract on file.

Term

Projected expiry 6 June 2027.

  1. Priority
  2. Filed
  3. Granted
  4. Today
  5. Projected expiry

40 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
81158106United States of AmericaP
87144206United States of AmericaP
2007013553United States of AmericaW

Members40

Family members, oldest first
DocumentOfficeKind
US2007281317A1United States of AmericaA1
AU2007258455A1AustraliaA1
CA2659543A1CanadaA1
WO2007146154A1World Intellectual Property Organization (WIPO)A1
EP1945821A1European Patent Office (EPO)A1
EP2017356A2European Patent Office (EPO)A2
EP2017356A3European Patent Office (EPO)A3
EP2017356A8European Patent Office (EPO)A8
JP2009539379AJapanA
US7833716B2United States of AmericaB2
EP1945821B1European Patent Office (EPO)B1
US2011014623A1United States of AmericaA1
AT496144TThis recordAustriaT
ATE496144T1AustriaT1
DE602007012045D1GermanyD1
DK1945821T3DenmarkT3
ES2358296T3SpainT3
EP2345740A1European Patent Office (EPO)A1
US8034570B2United States of AmericaB2
EP2017356B1European Patent Office (EPO)B1
AT536424TAustriaT
ATE536424T1AustriaT1
US2012003651A1United States of AmericaA1
DK2017356T3DenmarkT3
PL2017356T3PolandT3
US8278052B2United States of AmericaB2
US2013029344A1United States of AmericaA1
JP2013027408AJapanA
JP5152929B2JapanB2
AU2007258455B2AustraliaB2
US8580510B2United States of AmericaB2
US2014066330A1United States of AmericaA1
JP5680606B2JapanB2
EP2345740B1European Patent Office (EPO)B1
CA2659543CCanadaC
US9284549B2United States of AmericaB2
US2016186249A1United States of AmericaA1
US10167500B2United States of AmericaB2
US2019024158A9United States of AmericaA9
USRE48909EUnited States of AmericaE